Oraderm is an Australian pharmaceutical company focused on helping people access dermatology innovation. Clear Skin Matters. Oraderm is a joint venture between Arrotex Pharmaceuticals, Australia’s largest locally owned pharmaceutical company, and Douglas Pharmaceuticals, owner of market leading Oratane® (isotretinoin), Zetin® (acitretin) and nutraceutical & health products. At Oraderm, we pride ourselves on supporting Dermatologists, Dermatology Nurses and Pharmacists in their quest to help patients with chronic skin conditions. We commercialise Oratane® for the treatment of severe acne and Zetin® for psoriasis and disorders of keratinisation. Oraderm has an exciting portfolio of new dermatology products under development and registration for the Australian market
Company Details
- Employees
- 4
- Founded
- -
- Address
- 15–17 Chapel Street, Cremorne,victoria 3121,australia
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Keywords
- Dermatology, Pharmaceuticals, Isotretinoin, Acitretin, Oratane®, Zetin®, Specialty Care Dermatology, psoriasis, acne.
- HQ
- Cremorne, Victoria
Oraderm Australia Questions
Oraderm Australia's LinkedIn profile is https://au.linkedin.com/company/oraderm-australia
Oraderm Australia has
4 employees.
View email and phone details for 4
employees at Oraderm Australia.
Oraderm Australia's industry is
Pharmaceutical Manufacturing
Oraderm Australia's top competitors are
Maxiblock Sunscreen,
Dbg Health,
Biospectrum Asia,
Heritage Brands,
Marshalls+dent+wilmoth,
Vietnam - Australia Startups & Innovation Association (Vasia),
Chiesi Australia,
Invengene Private Limited,
Sunset Daze,
Skinb5™.
Oraderm Australia's categories are Pharmaceutical Manufacturing
Oraderm Australia's founding year is 2017
